Physician profile
Ling Jin
NPI 1386138956
$4,193.99
in general payments reported to CMS, 2019-2025
19 companies · $599 in 2025
The $599 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $292 · 2021: $41.44 · 2022: $365 · 2023: $2,024 · 2024: $382 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257 · Travel and Lodging: $918 · Education: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.10 |
| Travel and Lodging | $917.76 |
| Education | $830.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,255.34 | 2023 | Advisa Dr Mri Surescan, Harmony |
| Abbott Laboratories | $1,046.77 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite, Cardiomems |
| Cvrx, INC. | $420.34 | 2023-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $256.21 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $182.40 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $161.82 | 2025 | Optimizer |
| Pfizer INC. | $142.81 | 2019-2020 | |
| Abiomed | $135.65 | 2024-2025 | Impella |
| Alnylam Pharmaceuticals INC. | $127.45 | 2022-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $121.92 | 2019 | |
| United Therapeutics Corporation | $93.23 | 2022 | |
| Atricure, INC. | $69.24 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Cardiva Medical, INC. | $35.29 | 2024 | Cardiva Vascade 6/7f Vcs |
| Glaxosmithkline, LLC. | $34.96 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.75 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.35 | 2024 | Watchman Flx |
| Viiv Healthcare Company | $23.08 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.11 | 2021 | |
| Medtronic Vascular, INC. | $15.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ling Jin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.